Sleep ventilatory disorders are prevalent and include, commonly, both obstructive and central sleep apnea. Positive airway pressure therapy, although widely used, has inherent drawbacks, clinically. Alternative treatment modalities have been approved and hold interest within certain spheres.
Dr. Richard Knudsen of the Pacific Sleep Tech in Aiea, Hawaii reviews the first-in-class, novel “electroceuticals” in this article. These “electroceuticals” rely on the pathway of neural signal modulation via products that regulate the firing of neural circuits, in contradistinction to prescription drugs or pharmaceuticals that harbor untoward, systemic, and generalized side effects.
To view the complete article, click here and log in.